Skip to main content
. Author manuscript; available in PMC: 2016 Dec 13.
Published in final edited form as: Immunol Rev. 2016 Mar;270(1):178–192. doi: 10.1111/imr.12391

Fig. 3. Overview of commonly used scFv-based antibody fragments.

Fig. 3

a) Shorter linkers force two scFv fragments to homo- or heterodimerize, resulting in a diabody fragment b) chain order and linker length variations lead to a great diversity of different bispecific antibody fragments